| Prev Close | 19.76 |
| Open | 19.71 |
| Day Low/High | 19.39 / 19.84 |
| 52 Wk Low/High | 14.80 / 20.71 |
| Volume | 120.00K |
| Avg Volume | 250.60K |
| Exchange | NASDAQ |
| Shares Outstanding | 36.80M |
| Market Cap | 732.42M |
| EPS | 0.10 |
| P/E Ratio | 497.50 |
| Div & Yield | N.A. (N.A) |
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Michael C.
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Jim Clemmer,...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that the United States...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced financial results for the...
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: EVA, FSBC, GTE, SND, UWN Downgrades: ANGO, PCG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Jim Clemmer,...
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report...
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANGO, NKSH, OBCI, RGS, SGMA Downgrades: AIG, GGP Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against AngioDynamics, Inc.
The most recent short interest data was recently released for the 06/30/2017 settlement date, and AngioDynamics Inc is one of the most shorted stocks of the Russell 3000, based on 6.90 "days to cover" versus the median component at 4.17. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Girard Gibbs LLP is investigating potential claims on behalf of investors of AngioDynamics, Inc.
Levi & Korsinsky announces it has commenced an investigation of AngioDynamics, Inc.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Endo International slipped 5% ahead of market's open Friday.
